Abstract
Background: Severe traumatic brain injury (TBI) is associated with a 30%–70% mortality rate. S100B has been proposed as a biomarker for indicating outcome after TBI. Nevertheless, controversy has arisen concerning the predictive value of S100B for severe TBI in the context of multitrauma. Therefore, our aim was to determine whether S100B serum levels correlate with primary outcome following isolated severe TBI or multitrauma in males.
Methods: Twenty-three consecutive male patients (age 18–65years), victims of severe TBI [Glasgow Coma Scale (GCS) 3–8] (10 isolated TBI and 13 multitrauma with TBI) and a control group consisting of eight healthy volunteers were enrolled in this prospective study. Clinical outcome variables of severe TBI comprised: survival, time to intensive care unit (ICU) discharge, and neurological assessment [Glasgow Outcome Scale (GOS) at ICU discharge]. Venous blood samples were taken at admission in the ICU (study entry), 24h later, and 7days later. Serum S100B concentration was measured by an immunoluminometric assay.
Results: At study entry (mean time 10.9h after injury), mean S100B concentrations were significantly increased in the patient with TBI (1.448μg/L) compared with the control group (0.037μg/L) and patients with fatal outcome had higher mean S100B (2.10μg/L) concentrations when compared with survivors (0.85μg/L). In fact, there was a significant correlation between higher initial S100B concentrations and fatal outcome (Spearman's =0.485, p=0.019). However, there was no correlation between higher S100B concentrations and the presence of multitrauma. The specificity of S100B in predicting mortality according to the cut-off of 0.79μg/L was 73% at study entry.
Conclusions: Increased serum S100B levels constitute a valid predictor of unfavourable outcome in severe TBI, regardless of the presence of associated multitrauma.
Clin Chem Lab Med 2006;44:1234–42.
References
1. Bruns JR, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 2003; 44:2–10.10.1046/j.1528-1157.44.s10.3.xSearch in Google Scholar
2. Kraus JF, MacArthur DL, Silverman TA, Jayaraman N. Epidemiology of brain injury. In: Narayan RK, Wilberger Jr JE, Povlishock JT, editors. Neurotrauma. New York: McGraw-Hill, 1996:13–30.Search in Google Scholar
3. Ghajar J. Traumatic brain injury. Lancet 2000; 356:923–9.10.1016/S0140-6736(00)02689-1Search in Google Scholar
4. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 1998; 15:573–85.10.1089/neu.1998.15.573Search in Google Scholar
5. Duff D. Altered states of consciousness, theories of recovery and assessment following a severe traumatic brain injury. Axone 2003; 23:18–23.Search in Google Scholar
6. Faden AL. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 2002; 15:707–12.10.1097/01.wco.0000044767.39452.bfSearch in Google Scholar
7. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003; 23:137–49.10.1097/01.WCB.0000044631.80210.3CSearch in Google Scholar
8. Petzold A, Green AJE, Keir G, Fairley S, Kitchen N, Smith M, et al. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study. Crit Care Med 2002; 30:2705–10.10.1097/00003246-200212000-00015Search in Google Scholar
9. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. Serum S100B: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003; 97:2806–13.10.1002/cncr.11409Search in Google Scholar
10. Elting J-W, Jager AE, Teelken AW, Schaaf MJ, Maurits NM, Van Der Naalt J, et al. Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J Neurol Sci 2000; 181:104–10.10.1016/S0022-510X(00)00442-1Search in Google Scholar
11. Jönsson H, Johnsson P, Höglund P, Alling C, Blomquist S. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000; 14:698–701.10.1053/jcan.2000.18444Search in Google Scholar PubMed
12. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29:2363–6.10.1161/01.STR.29.11.2363Search in Google Scholar PubMed
13. Mussack T, Biberthaler P, Kanz K, Wiedemann E, Mutschler W, et al. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med 2002; 30:2669–74.10.1097/00003246-200212000-00010Search in Google Scholar PubMed
14. Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R. Serum S100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci 2003; 21:159–69.Search in Google Scholar
15. Regner A, Kaufman M, Friedman G, Chemale I. Increased serum S100B protein concentrations following severe head injury in humans: a biochemical marker of brain death? NeuroReport 2001; 12:691–4.10.1097/00001756-200103260-00015Search in Google Scholar PubMed
16. Rosén H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 1998; 29:473–7.10.1161/01.STR.29.2.473Search in Google Scholar PubMed
17. Snyder-Ramos SA, Böttiger BW. Molecular markers of brain damage – clinical and ethical implications with particular focus on cardiac arrest. Restor Neurol Neurosci 2003; 21:123–39.Search in Google Scholar
18. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45:468–76.10.1097/00006123-199909000-00010Search in Google Scholar PubMed
19. Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir Wien 1998; 140:787–92.10.1007/s007010050180Search in Google Scholar PubMed
20. Anderson RE, Hansson L-O, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001; 48:1255–60.Search in Google Scholar
21. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000; 17:367–88.10.1089/neu.2000.17.367Search in Google Scholar PubMed
22. Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH. The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2000; 279:H1015–21.10.1152/ajpheart.2000.279.3.H1015Search in Google Scholar PubMed
23. Lai YC, Chen FG, Goh MH, Koh KF. Predictors of long-term outcome in severe head injury. Ann Acad Med Singapore 1998; 27:326–31.Search in Google Scholar
24. Masson F, Thicoipe M, Mokui T, Aye P, Erny P, Dabadie P. Epidemiology of traumatic comas: a prospective population-based study. Brain Injury 2003; 17:279–93.10.1080/0269905021000030805Search in Google Scholar PubMed
25. Leone M, Albanase J, Rousseau S, Antonini F, Dubuc M, Alliez B, et al. Pulmonary contusion in severe head trauma patient: impact on gas exchange and outcome. Chest 2003; 124:2261–6.10.1378/chest.124.6.2261Search in Google Scholar PubMed
26. Zagara G, Scaravilli P, Mastorgio P, Seveso M. Validation of a prognostic system in severe brain-injured patients. J Neurosurg Sci 1992; 35:77–81.Search in Google Scholar
27. Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Neurol Neurosurg Psychiatry 2001; 70:95–100.10.1136/jnnp.70.1.95Search in Google Scholar PubMed PubMed Central
28. Hu J, Ferreira A, van Eldik LJ. S100B induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997; 69:2294–301.10.1046/j.1471-4159.1997.69062294.xSearch in Google Scholar
29. McAdory BS, van Eldik LJ, Norden JJ. S100B, a neurotrophic protein that modulates neuronal protein phosphorylation, is upregulated during lesion-induced collateral sprouting and reactive synaptogenesis. Brain Res 1998; 813:211–7.10.1016/S0006-8993(98)01014-2Search in Google Scholar
30. Neuwelt EA. Mechanisms of disease: the blood-brain barrier. Neurosurgery 2004; 54:131–40.10.1227/01.NEU.0000097715.11966.8ESearch in Google Scholar
31. Petzold A, Keir G, Lim D, Smith M, Thompson EJ. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 2003; 61:281–5.10.1016/S0361-9230(03)00091-1Search in Google Scholar
32. Woertgen C, Rothoerl D, Brawanski A. Early S-100B serum level correlates to quality of life in patients after severe head injury. Brain Injury 2002; 16:807–16.10.1080/02699050210128933Search in Google Scholar
33. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, et al. Protein S-100b serum levels in trauma-induced brain death. Neurology 2003; 60:947–51.10.1212/01.WNL.0000049931.77887.7FSearch in Google Scholar
34. Marshall LF. Head injury: recent past, present, and future. Neurosurgery 2000; 47:546–61.Search in Google Scholar
35. Da Rocha AB, Zanoni C, de Freitas GR, Andre C, Himelfarb S, Schneider R, et al. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J Neurotrauma 2005; 15:385–92.10.1089/neu.2005.22.966Search in Google Scholar
36. Pelinka LE, Kroepfl A, Schmidhammer R, Redl H. Serum procalcitonin and S100B are associated with mortality after traumatic brain injury. Eur J Trauma 2003; 5:316–23.10.1007/s00068-003-1314-4Search in Google Scholar
37. Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch C-W. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci 1999; 14:109–14.Search in Google Scholar
38. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma 1998; 45:765–7.10.1097/00005373-199810000-00025Search in Google Scholar
39. Mussack T, Biberthaler P, Gippner-Steppert C, Kanz KG, Wiedemann E, Mutschler W, et al. Early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated severe head trauma: a comparative pilot study on common pathomechanisms. Resuscitation 2001; 49:193–9.10.1016/S0300-9572(00)00346-4Search in Google Scholar
40. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: a role for protein S-100B? J Neurol Neurosurg Psychiatry 2002; 73:542–6.10.1136/jnnp.73.5.542Search in Google Scholar
41. Finfer SR, Cohen J. Severe traumatic brain injury. Resuscitation 2001; 48:77–90.10.1016/S0300-9572(00)00321-XSearch in Google Scholar
42. Jönsson H. S100B and cardiac surgery: possibilities and limitations. Restor Neurol Neurosci 2003; 21:151–7.Search in Google Scholar
43. Pelinka LE, Szalay L, Jafarmadar M, Schmidhammer R, Redl H, Bahrami S. Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br J Anaesth 2003; 91:595–7.10.1093/bja/aeg225Search in Google Scholar PubMed
44. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 2004; 56:1229–34.10.1097/01.TA.0000096644.08735.72Search in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
